Stock Events

Stock Events

NeuroSense Therapeutics (NRSN) Q2 2024 Earnings

24JunConfirmed

Q2 2023

Q3 2023

Q1 2024

Q2 2024

-0.35

-0.2

-0.05

0.1

Details

Expected EPS

-0.205

Actual EPS

-0.35

Surprise EPS

-0.15

Surprise Percent

+70.73%

Description

NeuroSense Therapeutics (NRSN) has reported earnings of -0.35 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.